Zdrowie i gospodarka · 29/05/2007
FDA Announces Enforcement Action Against Unapproved Guaifenesin-Containing Timed-Release Drugs
The FDA is taking enforcement action against hundreds of unapproved timed-release drug products containing guaifenesin, which are marketed to relieve symptoms of cough, cold, and similar conditions, and against individuals who manufacture or ship these products without approval.